Orthofix International | OFIX - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Dexcom USD 300M 58.9M 2025-09
EDAP TMS EUR -4.91M 597K 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Hologic USD 229.7M 2.3M 2025-12
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
J&J USD 4.97B 2.53B 2025-12
Medtronic USD 2.1B 224M 2025-09
Mesa Laboratories USD -2.22M 6.03M 2024-12
Orthofix International USD -2.19M 20.07M 2025-12
Smith & Nephew USD 469M 70M 2025-12
STAAR Surgical USD 18.79M 44.7M 2025-09
Stryker USD 1.03B 13M 2025-09
Surmodics USD -7.51M 1.69M 2024-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Veracyte USD 40.63M 21.74M 2025-12
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09